Free thyroxine levels after very preterm birth and neurodevelopmental outcomes at age 7 years

Shannon E Scratch1, Rodney W Hunt, Deanne K Thompson

  • 1Clinical Sciences, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia;

Pediatrics
|April 2, 2014
PubMed

Insights

Higher postnatal free thyroxine (fT₄) levels in very preterm infants are linked to poorer cognitive function at age 7. This finding contrasts with previous research and suggests fT₄ may be a marker for adverse neurodevelopmental outcomes.

Area of Science:

  • Neonatalogy
  • Neuroscience
  • Endocrinology

Background:

  • Transient hypothyroxinemia of prematurity is common in preterm infants.
  • Previous research linked low thyroxine to cognitive deficits, focusing on early life and preschool outcomes.
  • The impact of longer-term thyroid hormone levels on later cognitive development remains less understood.

Purpose of the Study:

  • To investigate the association between free thyroxine (fT₄) levels during the first 6 weeks after birth and cognitive function at age 7 years in very preterm infants.
  • To explore the relationship between fT₄ levels and brain development in this population.

Main Methods:

  • Studied 83 very preterm infants (<30 weeks' gestation).
  • Measured postnatal free thyroxine (fT₄) concentrations and calculated 2- and 6-week area under the curve (AUC) measures.
  • Assessed cognitive function and brain development at age 7 years using neuropsychological tests and MRI.

Main Results:

  • Higher 2-week and 6-week postnatal fT₄ AUC levels were associated with poorer performance in verbal learning, verbal memory, and simple reaction time at age 7.
  • No significant associations were found between postnatal fT₄ levels and brain volumes at age 7.

Conclusions:

  • Contrary to prior studies, higher postnatal fT₄ levels in very preterm infants may be a marker for adverse neuropsychological development.
  • These findings highlight a potential shift in understanding the role of thyroid hormones in preterm neurodevelopment.
Abstract

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
5.8K
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
26
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K